Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Meeting Results for: September 14, 2016

Drugs and Therapeutics (D & T) Committee Meeting Results September 14, 2016
Drug Name	Review Type	Committee Recommendation	Prior Approval Status – Final Determination
Viekira XR	New Drug Initial Review	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Epclusa	New Drug Initial Review	Preferred with a Prior Approval	Preferred with a Prior Approval
Ocaliva	New Drug Initial Review	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Briviact	New Drug Initial Review	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Xtampza ER	New Drug Initial Review	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Adzenys XR-ODT	New Drug Initial Review	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)
Spinosad	New Drug Initial Review	Remove Prior Approval (Preferred)	Prior Approval Removed (Preferred)
Orenitram ER	New Drug Appeal	Require Prior Approval (Non-Preferred)	Prior Approval Required (Non-Preferred)